Home Europe EEA Joint Committee Decision of the EEA Joint Committee No 235/2024 of 25 Octobe...
Date: 20-Feb-2025 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 235/2024 of 25 October 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/253]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • The Decision of the EEA Joint Committee No 235/2024 amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement to incorporate several Commission Implementing Regulations regarding novel foods.

Key Changes

  • The decision incorporates Commission Implementing Regulations (EU) 2024/1026, 2024/1027, 2024/1037, 2024/1046, 2024/1047, 2024/1048 and 2024/1052 into the EEA Agreement.
  • These regulations authorize the placing on the market of several novel foods, including astaxanthin-rich oleoresin from Haematococcus pluvialis algae, galacto-oligosaccharide, monosodium salt of L-5-methyltetrahydrofolic acid, beta-glucan from Euglena gracilis microalgae, 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637), protein concentrate from Lemna gibba and Lemna minor and calcidiol monohydrate.
  • The decision amends Chapter XII of Annex II to the EEA Agreement by adding indents to point 124b and inserting new points after point 245 to reflect the incorporation of the aforementioned regulations.
  • The decision does not apply to Liechtenstein as long as the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein.

Impact Analysis

Food Producers and Manufacturers

  • Action Items: Review the specifications and conditions of use for each novel food as outlined in the respective Commission Implementing Regulations. Ensure compliance with labeling and compositional requirements.

Consumers

  • Action Items: No direct action required. Consumers may benefit from increased availability of food products with potentially enhanced nutritional profiles.

Regulatory Bodies

  • Action Items: Update internal procedures and guidelines to reflect the incorporation of these regulations. Monitor the market to ensure compliance and address any potential safety concerns.

Liechtenstein

  • Action Items: Monitor the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products to Liechtenstein to determine the applicability of this decision in the future.

Key Entities Referenced

EEA Joint Committee: The governing body responsible for decisions related to the EEA Agreement. European Commission: The executive branch of the European Union, responsible for proposing and implementing legislation. EEA Agreement: The Agreement on the European Economic Area, extending the EU's internal market to Iceland, Liechtenstein and Norway. Commission Implementing Regulation (EU) 2017/2470: Regulation laying down implementing rules for novel foods. Commission Implementing Regulation (EU) 2024/1026: Commission Implementing Regulation amending Implementing Regulation (EU) 2017/2470 as regards the specifications of the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae. Commission Implementing Regulation (EU) 2024/1027: Commission Implementing Regulation amending Implementing Regulation (EU) 2017/2470 as regards the specifications of the novel food galacto-oligosaccharide. Commission Implementing Regulation (EU) 2024/1037: Commission Implementing Regulation authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food and amending Implementing Regulation (EU) 2017/2470. Commission Implementing Regulation (EU) 2024/1046: Commission Implementing Regulation authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/2470. Commission Implementing Regulation (EU) 2024/1047: Commission Implementing Regulation authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470. Commission Implementing Regulation (EU) 2024/1048: Commission Implementing Regulation authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food and amending Implementing Regulation (EU) 2017/2470. Commission Implementing Regulation (EU) 2024/1052: Commission Implementing Regulation authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470. Liechtenstein: A country within the EEA to which this decision may not apply under certain conditions.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2025/253 20.2.2025 DECISION OF THE EEA JOINT COMMITTEE No 235/2024 of 25 October 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/253] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Regulation (EU) 2024/1026 of 8 April 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications of the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae(1)is to be incorporated into the EEA Agreement. (2) Commission Implementing Regulation (EU) 2024/1027 of 8 April 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications of the novel food galacto-oligosaccharide(2)is to be incorporated into the EEA Agreement. (3) Commission Implementing Regulation (EU) 2024/1037 of 9 April 2024authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food and amending Implementing Regulation (EU) 2017/2470(3)is to be incorporated into the EEA Agreement. (4) Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/2470(4)is to be incorporated into the EEA Agreement. (5) Commission Implementing Regulation (EU) 2024/1047 of 9 April 2024authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470(5)is to be incorporated into the EEA Agreement. (6) Commission Implementing Regulation (EU) 2024/1048 of 9 April 2024authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food and amending Implementing Regulation (EU) 2017/2470(6)is to be incorporated into the EEA Agreement. (7) Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470(7) is to be incorporated into the EEA Agreement. (8) This Decision concerns legislation regarding foodstuffs. Legislation regarding foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein. (9) Annex II to the EEA Agreement should therefore be amended accordingly, (1) OJ L, 2024/1026, 9.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1026/oj. (2) OJ L, 2024/1027, 9.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1027/oj. (3) OJ L, 2024/1037, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1037/oj. (4) OJ L, 2024/1046, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1046/oj. (5) OJ L, 2024/1047, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1047/oj. (6) OJ L, 2024/1048, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1048/oj. (7) OJ L, 2024/1052, 11.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1052/oj. ELI: http://data.europa.eu/eli/dec/2025/253/oj 1/3EN OJ L, 20.2.2025 HAS ADOPTED THIS DECISION: Article 1 Chapter XII of Annex II to the EEA Agreement shall be amended as follows: 1. The following indents are added in point 124b (Commission Implementing Regulation (EU) 2017/2470): ‘— 32024 R 1026: Commission Implementing Regulation (EU) 2024/1026 of 8 April 2024 (OJ L, 2024/1026, 9.4.2024), — 32024 R 1027: Commission Implementing Regulation (EU) 2024/1027 of 8 April 2024 (OJ L, 2024/1027, 9.4.2024), — 32024 R 1037: Commission Implementing Regulation (EU) 2024/1037 of 9 April 2024 (OJ L, 2024/1037, 10.4.2024), — 32024 R 1046: Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024 (OJ L, 2024/1046, 10.4.2024), — 32024 R 1047: Commission Implementing Regulation (EU) 2024/1047 of 9 April 2024 (OJ L, 2024/1047, 10.4.2024), — 32024 R 1048: Commission Implementing Regulation (EU) 2024/1048 of 9 April 2024 (OJ L, 2024/1048, 10.4.2024), — 32024 R 1052: Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024(OJ L, 2024/1052, 11.4.2024).’ 2. The following points are inserted after point 245 (Commission Implementing Regulation (EU) 2023/2851): ‘246. 32024 R 1037: Commission Implementing Regulation (EU) 2024/1037 of 9 April 2024 authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1037, 10.4.2024). 247. 32024 R 1046: Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1046, 10.4.2024). 248. 32024 R 1047: Commission Implementing Regulation (EU) 2024/1047 of 9 April 2024 authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1047, 10.4.2024). 249. 32024 R 1048: Commission Implementing Regulation (EU) 2024/1048 of 9 April 2024 authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1048, 10.4.2024). 250. 32024 R 1052: Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1052, 11.4.2024).’ Article 2 The texts of Implementing Regulations (EU) 2024/1026, (EU) 2024/1027, (EU) 2024/1037, (EU) 2024/1046, (EU) 2024/1047, (EU) 2024/1048 and (EU) 2024/1052 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. 2/3 ELI: http://data.europa.eu/eli/dec/2025/253/ojEN OJ L, 20.2.2025 Article 3 This Decision shall enter into force on 26 October 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made(*). Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 25 October 2024. For the EEA Joint Committee The President Anders H. EIDE (*) No constitutional requirements indicated. ELI: http://data.europa.eu/eli/dec/2025/253/oj 3/3

Continue your research